Vention Medical, Inc. has acquired ATEK Medical Group
Vention Medical Inc., a leading full-service medical device outsourcing company, has acquired ATEK Medical Group. Financial details of this transaction have not been disclosed.
Vention Medical is controlled by KRG Capital Partners, L.L.C., a Denver, Colorado-based private equity firm with a US$2 billion investment fund.
ATEK Medical Group is a leader in medical device assembly, packaging and injection molding, with facilities in Grand Rapids, Michigan, and Kerrville, Texas in the USA, and Heredia in Costa Rica.
One of Oaklins' teams in the USA advised the buyer in this transaction. The team has represented Vention Medical on three separate transactions including a recapitalization and two add-on acquisitions.
Talk to the deal team
Paul R. Smolevitz
Oaklins TM Capital
Related deals
EuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreTEAM Safety Services Limited has been acquired by Vadella Group
TEAM Safety Services Limited, a leading UK-based health, safety and fire safety consultancy, has been acquired by Vadella Group, a specialist provider of inspection-led compliance services for the built environment.
Learn moreMEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn more